Cross-sectional study to evaluate positivity in women tested for and , attending genitourinary medicine and primary care clinics in Bristol, South West England.

Background: Highly sensitive, commercial nucleic acid amplification tests (NAAT) for have only recently been recommended for use in the UK. While testing for is routine in symptomatic women attending genitourinary medicine (GUM) clinics, it is rare in asymptomatic women or those attending primary care. The aim of this study was to evaluate the positivity of using a commercial NAAT, in symptomatic and asymptomatic women undergoing testing for chlamydia and gonorrhoea in GUM and primary care settings.